Information Provided By:
Fly News Breaks for March 14, 2019
SIEN
Mar 14, 2019 | 07:54 EDT
Wells Fargo analyst David Maris started coverage of Sientra with a Market Perform rating and a $9 price target. The analyst says he is on the sidelines given the FDA is holding meetings on March 25-26 to discuss breast implant safety and the result could be increased monitoring and warnings, which could have a negative impact on costs and volumes.
News For SIEN From the Last 2 Days
There are no results for your query SIEN